Indivior (INDVL)

887.50p
   
  • Change Today:
      29.00p
  • 52 Week High: 1,448.00
  • 52 Week Low: 577.50
  • Currency: UK Pounds
  • Shares Issued: 718.58m
  • Volume: 34,332
  • Market Cap: £6,377m

Deal with Barclays    Trade now with Barclays Stockbrokers

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn -1.9%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue 7.0
Pr/Book n/a
Latest F'cast
Revenue 8.7%
PBT n/a
EPS n/a
DPS n/a

Indivior Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 647.00 (173.00) 40.00¢ 3.6 n/a -67% n/a 0.0%
31-Dec-21 791.00 190.00 19.20¢ 18.0 n/a -52% n/a 0.0%
31-Dec-22 901.00 (95.00) (38.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1,093.00 1.00 1.00¢ 1,601.7 n/a n/a n/a 0.0%
31-Dec-24 1,188.00 (43.00) (36.00)¢ n/a n/a n/a n/a 0.0%

Indivior Company Announcements

Share Consolidation and Total Voting Rights 10-Oct-2022 08:15 RNS

Indivior ShareCast News

No recent information was found.

Latest Indivior Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Indivior Market Data

Currency UK Pounds
Share Price 887.50p
Change Today 29.00p
% Change 3.38 %
52 Week High 1,448.00
52 Week Low 577.50
Volume 34,332
Shares Issued 718.58m
Market Cap £6,377m

Trades for 28-May-2025

Time Volume / Share Price
14:41 48 @ 887.50p
14:41 7 @ 887.50p
14:41 99 @ 887.50p
14:41 52 @ 886.00p
14:41 193 @ 886.50p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page